These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2729418)

  • 1. Bromocriptine therapy for thyroid ophthalmopathy.
    Lopatynsky MO; Krohel GB
    Am J Ophthalmol; 1989 Jun; 107(6):680-1. PubMed ID: 2729418
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive effect of bromocriptine treatment in Graves disease orbitopathy.
    Kołodziej-Maciejewska H; Reterski Z
    Exp Clin Endocrinol; 1985 Dec; 86(2):241-2. PubMed ID: 3841515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immediate results of parlodel treatment of patients with diffuse toxic goiter complicated by endocrine ophthalmopathy].
    Kazeev KN; Zinkevich IV; Karaseva GI; Kostareva LN
    Probl Endokrinol (Mosk); 1987; 33(1):3-5. PubMed ID: 3823019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' hyperthyroidism and ophthalmopathy associated with pemphigus vulgaris: onset of thyroid autoimmune disease during chronic low-dose glucocorticoid therapy.
    Bartalena L; Bogazzi F; Chiovato L; Tanda ML; Martino E
    J Endocrinol Invest; 1997 Mar; 20(3):155-7. PubMed ID: 9186823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapies in patients with Graves' ophthalmopathy].
    Wang J; Wang YT; Shao JQ; Wang X; Du H
    Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):125-7. PubMed ID: 15059413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
    Bartalena L; Marcocci C; Bogazzi F; Panicucci M; Lepri A; Pinchera A
    N Engl J Med; 1989 Nov; 321(20):1349-52. PubMed ID: 2811943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy.
    Wiersinga WM; Smit T; Schuster-Uittenhoeve AL; van der Gaag R; Koornneef L
    Ophthalmologica; 1988; 197(2):75-84. PubMed ID: 3186212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' ophthalmopathy. An unusual course.
    Khardori R; Weaver ME; Soler NG
    Am J Med; 1984 Dec; 77(6):1121-5. PubMed ID: 6548874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic role of adhesion molecules sELAM-1 and sICAM-1 in glucocorticoid therapy of active ophthalmopathy].
    Modelska-Ziółkiewicz A; Gembicki M; Bednarek J; Sowiński J
    Pol Arch Med Wewn; 2003 May; 109(5):469-75. PubMed ID: 14768175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
    N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisone treatment in endocrine ophthalmopathy.
    Apers RC; Oosterhuis JA; Goslings BM; Bierlaagh JJ
    Mod Probl Ophthalmol; 1975; 14():414-20. PubMed ID: 1242207
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucocorticoid treatment of progressive infiltrative ophthalmopathy.
    Mulherin JL; Temple TE; Cundey DW
    South Med J; 1972 Jan; 65(1):77-80. PubMed ID: 5066715
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
    Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined irradiation and low-dose cyclophosphamide in the treatment of Graves' ophthalmopathy.
    Teoh R; Woo J
    Postgrad Med J; 1987 Sep; 63(743):777-9. PubMed ID: 3444803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
    DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C]
    J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Graves' ophthalmopathy.
    Utiger RD
    N Engl J Med; 1989 Nov; 321(20):1403-5. PubMed ID: 2811946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug treatment of Graves' ophthalmopathy].
    Prummel MF; Wiersinga WM
    Ned Tijdschr Geneeskd; 1990 May; 134(19):938-40. PubMed ID: 1693417
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.